Teton Advisors LLC Purchases Shares of 110,200 Ultralife Corporation $ULBI

Teton Advisors LLC acquired a new position in shares of Ultralife Corporation (NASDAQ:ULBI) in the 3rd quarter, HoldingsChannel reports. The firm acquired 110,200 shares of the technology company’s stock, valued at approximately $752,000.

Other institutional investors also recently modified their holdings of the company. Lazard Asset Management LLC boosted its holdings in shares of Ultralife by 1,650.0% in the 2nd quarter. Lazard Asset Management LLC now owns 5,565 shares of the technology company’s stock worth $49,000 after acquiring an additional 5,247 shares in the last quarter. Bank of America Corp DE raised its position in Ultralife by 30.7% in the 4th quarter. Bank of America Corp DE now owns 12,067 shares of the technology company’s stock valued at $90,000 after purchasing an additional 2,836 shares during the last quarter. Qube Research & Technologies Ltd acquired a new position in Ultralife in the second quarter worth $134,000. Jones Financial Companies Lllp increased its stake in shares of Ultralife by 1,428.7% in the first quarter. Jones Financial Companies Lllp now owns 15,287 shares of the technology company’s stock valued at $82,000 after buying an additional 14,287 shares in the last quarter. Finally, Occudo Quantitative Strategies LP bought a new position in shares of Ultralife in the second quarter valued at about $142,000. Institutional investors own 30.68% of the company’s stock.

Insider Activity

In other Ultralife news, Director Bradford T. Whitmore bought 28,588 shares of Ultralife stock in a transaction dated Tuesday, December 16th. The shares were bought at an average price of $5.70 per share, with a total value of $162,951.60. Following the purchase, the director owned 1,235,631 shares of the company’s stock, valued at $7,043,096.70. This trade represents a 2.37% increase in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is available at this link. Over the last 90 days, insiders have bought 53,000 shares of company stock valued at $300,838. 40.00% of the stock is currently owned by company insiders.

Wall Street Analyst Weigh In

Separately, Weiss Ratings reissued a “sell (d+)” rating on shares of Ultralife in a report on Monday, December 29th. One research analyst has rated the stock with a Sell rating, According to MarketBeat, the stock currently has a consensus rating of “Sell”.

Ultralife Price Performance

Ultralife stock opened at $5.25 on Friday. The business’s 50-day simple moving average is $6.12 and its 200 day simple moving average is $6.32. The company has a quick ratio of 1.42, a current ratio of 2.99 and a debt-to-equity ratio of 0.34. The stock has a market cap of $87.41 million, a price-to-earnings ratio of 52.50 and a beta of 0.88. Ultralife Corporation has a 12-month low of $4.07 and a 12-month high of $9.52.

Ultralife Profile

Ultralife Corporation (NASDAQ: ULBI) develops, manufactures and sells a broad range of energy and communications products for defense, medical, automotive and consumer electronics markets. The company operates through two primary segments: Power Systems and Communications Systems. In its Power Systems segment, Ultralife produces lithium-ion rechargeable cells and battery packs, primary lithium batteries, alkaline and rechargeable battery packs, chargers and battery accessories designed to meet demanding performance and safety requirements.